ロード中...
NK cells mediate clearance of CD8(+) T cell–resistant tumors in response to STING agonists
Several immunotherapy approaches that mobilize CD8(+) T cell responses stimulate tumor rejection, and some, such as checkpoint blockade, have been approved for several cancer indications and show impressive increases in patient survival. However, tumors may evade CD8(+) T cell recognition via loss o...
保存先:
| 出版年: | Sci Immunol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228660/ https://ncbi.nlm.nih.gov/pubmed/32198222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.aaz2738 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|